Tempus Ai, INC Form 4 insider transactions

Thomas Edward Schoenherr, CEO, Diagnostics of Tempus AI, Inc., sold 10,281 shares of common stock on September 25, 2026 for $85.00 per share.

Eric P Lefkofsky, CEO and Chairman, a Director and 10% owner of Tempus AI, Inc., sold 250,000 shares of common stock on September 22, 2026.

Eric P Lefkofsky, CEO and Chairman, a Director and 10% owner of Tempus AI, Inc., sold 200,000 shares of common stock on September 17, 2026.

Ryan M Bartolucci, Chief Accounting Officer of Tempus AI, Inc., sold 7,062 shares of common stock on September 17, 2026 for $75.00 per share.

Andrew Polovin, EVP, Chief Legal Officer of Tempus AI, Inc., sold 2,951 shares of common stock on September 17, 2026 for $75.00 per share.

Ryan Fukushima, CEO, Data of Tempus AI, Inc., sold 700 shares of common stock on September 16, 2026 for $70.00 per share.

Tempus AI CEO Eric Lefkofsky discusses strong Q2 results, the strategic acquisition of Personalis, and the accelerating demand for AI-driven solutions in biopharma.

Eric P Lefkofsky, CEO and Chairman, a Director and 10% owner of Tempus AI, Inc., sold 11,848 shares of common stock on August 25, 2026.

Eric P Lefkofsky, CEO and Chairman, a Director and 10% owner of Tempus AI, Inc., sold 238,152 shares of common stock on August 25, 2026.

Thomas Edward Schoenherr, CEO, Diagnostics of Tempus AI, Inc., reported a transaction in 2,694 shares of common stock on August 21, 2026.

Ryan Fukushima, CEO, Data of Tempus AI, Inc., sold 14,286 shares of common stock on August 21, 2026 for $70.00 per share.

Ryan Fukushima, CEO, Data of Tempus AI, Inc., sold 41,095 shares of common stock on August 18, 2026 for $49.61 per share.

Eric P Lefkofsky, CEO and Chairman, a Director and 10% owner of Tempus AI, Inc., sold 132,591 shares of common stock on August 18, 2026 for $49.61 per share.

Thomas Edward Schoenherr, CEO, Diagnostics of Tempus AI, Inc., sold 17,314 shares of common stock on August 18, 2026.

James William Rogers, Chief Financial Officer of Tempus AI, Inc., sold 48,842 shares of common stock on August 18, 2026.

Andrew Polovin, EVP, Chief Legal Officer of Tempus AI, Inc., sold 30,075 shares of common stock on August 18, 2026.

Ryan M Bartolucci, Chief Accounting Officer of Tempus AI, Inc., sold 6,175 shares of common stock on August 18, 2026 for $49.61 per share.

Ryan Fukushima, CEO, Data of Tempus AI, Inc., reported a transaction in 62,239 shares of common stock on August 12, 2026.

Ryan Fukushima, CEO, Data of Tempus AI, Inc., sold 20,000 shares of common stock on August 7, 2026 for $50.04 per share.

Andrew Polovin, EVP, Chief Legal Officer of Tempus AI, Inc., received 40,000 shares of common stock on July 29, 2026.

James William Rogers, Chief Financial Officer of Tempus AI, Inc., received 40,000 shares of common stock on July 29, 2026.

Eric P Lefkofsky, CEO and Chairman, a Director and 10% owner of Tempus AI, Inc., sold 250,000 shares of common stock on July 28, 2026.

Tempus AI announced a definitive agreement to acquire Personalis for $1.5 billion, aiming to enhance its oncology diagnostics and biopharma offerings.

Tempus AI announced its agreement to acquire Personalis, Inc., aiming to integrate genomic data and AI-driven insights.

Tempus AI announced its agreement to acquire Personalis, Inc. for $1.7 billion, aiming to integrate Personalis's ultrasensitive molecular residual disease (MRD) testing into its AI-enabled precision oncology platform.

Tempus AI, Inc. announced its entry into a definitive Agreement and Plan of Merger with Personalis, Inc., outlining the terms of a two-step merger transaction.

Tempus AI announced its definitive agreement to acquire Personalis, Inc. for $1.5 billion, aiming to integrate Personalis's minimal residual disease (MRD) technology into its AI-enabled precision oncology platform.

Ryan Fukushima, CEO, Data at Tempus AI, Inc., reported the sale of Class A Common Stock valued at over $3.5 million, executed under a pre-arranged trading plan.

Ryan Fukushima, CEO of Data at Tempus AI, Inc., reported a transaction involving Class A Common Stock under a Rule 10b5-1 trading plan.

Eric Lefkofsky, CEO and Chairman of Tempus AI, Inc., reported transactions involving the sale of Class A Common Stock.